Metastatic Cancer Clinical Trials in Chicago, Illinois
8 recruitingChicago, Illinois
Showing 1–8 of 8 trials
Recruiting
Phase 1
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815
Metastatic CancerAdvanced CancerSolid Tumor
Jazz Pharmaceuticals332 enrolled15 locationsNCT05557045
Recruiting
Optimizing Y90 Therapy for Radiation Lobectomy
Metastatic CancerHCCResection+2 more
Northwestern University104 enrolled2 locationsNCT04390724
Recruiting
Phase 1
STM-06: POLARIS-POlymetastic Lesion Ablative Radiotherapy With Immunotherapy Study
Advanced Solid TumorMetastatic Cancer
University of Illinois at Chicago28 enrolled1 locationNCT07269080
Recruiting
Phase 2
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
Metastatic CancerAdvanced CancerMalignant Neoplasm of Lung
Mirati Therapeutics Inc.200 enrolled120 locationsNCT05853575
Recruiting
Phase 2
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
Metastatic CancerCastration-resistant Prostate Cancer
Rana McKay, MD47 enrolled4 locationsNCT05502315
Recruiting
Phase 1
Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
Metastatic Cancer
University of Chicago264 enrolled2 locationsNCT04295863
Recruiting
Phase 1Phase 2
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
Metastatic CancerAdvanced Cancer
Qurient Co., Ltd.130 enrolled11 locationsNCT05394103
Recruiting
Phase 1
PRE-I-SPY Phase I/Ib Oncology Platform Program
Metastatic Breast CancerHER2-negative Breast CancerMetastatic Cancer+5 more
QuantumLeap Healthcare Collaborative124 enrolled7 locationsNCT05868226